CDC, DOH Issue Advisory on Oseltamivir/Tamiflu

The Centers for Disease Control and Prevention (CDC) and the Department of Health (DOH) have issued an advisory with guidance for clinicians to prioritize antiviral treatment of flu in the event of reduced availability of oseltamivir (Tamiflu). The guidance includes recommendations for hospital, outpatient, and long term care facility settings.